Can a rapid screening strategy improve infection control in critically ill patients?
Not Applicable
Completed
- Conditions
- Infection by ESBL or CPE bacteriaInfections and Infestations
- Registration Number
- ISRCTN23588440
- Lead Sponsor
- Hôpitaux Universitaires de Genève
- Brief Summary
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35672757/ (added 08/06/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 101
Inclusion Criteria
All patients admitted to the Intensive Care Units during the study period
Exclusion Criteria
N/A
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nnecessary pre-emptive isolation-days will be determined using Turn-Around-Times for ESBL/CPE screening and work up, with the help of computerized laboratory databases and a specific tool integrated into the electronic patient file, informed in real time by patient dedicated nurses. This outcome will be measured for all high-risk patient with a negative result for ESBL and CPE on a targeted screening at admission, at the time of discontinuation of pre-emptive isolation.
- Secondary Outcome Measures
Name Time Method <br> 1. Time between patient screening and implementation of contact precaution of previously unknown ESBL-PE and CPE carriers will be determined using Turn-Around-Times for ESBL/CPE screening and work up, with the help of computerized laboratory databases and a specific tool integrated into the electronic patient file, informed in real time by patient dedicated nurses. This outcome will be measured for all patients newly positive for ESBL and CPE on a weekly screening, at the time of implementation of contact precaution.<br> 2. Adjusted incidence-density ratio of nosocomial ESBL/CPE acquisition will be determined using surveillance data prospectively collected by infection control nurses. This outcome will be measured monthly.<br>